SYNLAB Founding Member of Global Diagnostics Network (GDN) – Combined Excellence in a Worldwide Community for Laboratory Diagnostics

The GDN, initiated by US-based Quest Diagnostics, brings together leading diagnostics services providers to share expertise and insights and drive worldwide diagnostics innovation

Together with other leading diagnostic services providers SYNLAB initiated the Global Diagnostics Network (GDN). The GDN is a strategic working group of diagnostic laboratories aiming to share expertise and insights to drive worldwide diagnostics innovation.

As leading medical diagnostic services provider in Europe, it is our responsibility and mission to provide the best and most actionable diagnostic services. We always put our customers in the centre of all our operations. As the greatest innovations derive from cooperation, the strongest market players have now bundled their resources to be able to significantly promote global healthcare and quality of life: In addition to SYNLAB, charter members are Quest Diagnostics (USA), Al Borg Medical Laboratories (Middle East), Dasa (Brazil), GC Labs (South Korea), KingMed Diagnostics (China), and Primary Health Care (Australia). Altogether, this alliance is present in countries with more than half of the world’s population across all continents.

Priority goal of the network will be the implementation of a global launch platform for high quality companion diagnostics. Furthermore, the alliance will create an emerging pathogen preparedness network to accelerate infectious disease research and response. These and other actions will not only benefit us as SYNLAB but also patients, referring practitioners, healthcare providers, pharmaceutical innovators, non-governmental organizations and many more.

“We are excited to be part of this global community of diagnostic excellence,” says Mathieu Floreani, CEO SYNLAB Group. “Together we set a sign for a new era of collaboration, jointly contributing to global healthcare with combined expertise, shared knowledge and innovation. We are proud to contribute our expertise and diagnostics innovation to the GDN which helps to offer new technologies and tests globally even faster than before. At the same time, the GDN strengthens our leading position in Europe and beyond.”

“The GDN collaboration will open up new opportunities to expedite innovation by removing silos around unique knowledge and resources,” commented Carrie Eglinton Manner, Senior Vice President, Advanced Diagnostics, Quest Diagnostics. “We see this as a pragmatic approach to driving growth and excellence for all network members, while providing customers global access to innovations in diagnostics science and service delivery.

For more information about the GDN, please visit www.globaldiagnosticsnetwork.com